Physician Assistant · Ann Arbor, MI
NPI
1790254290
Since 2018
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1500 E Medical Center Dr
Ann Arbor, MI, 48109
Phone (734) 936-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
407 services
Medicare patients, 2024
145
Average age 52
Drug cost, 2024
$1.1M
1,994 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allyson R Cunningham was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 96 times for 84 patients. In total Allyson R Cunningham billed 407 services in 12 codes, and Medicare paid $16K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 96 | 84 | $10.36 | $995 |
| 99215 Office E&M - Established | Facility | 78 | 69 | $82.24 | $6,414 |
| 99213 Office E&M - Established | Facility | 41 | 35 | $42.77 | $1,753 |
| 99214 Office E&M - Established | Facility | 30 | 29 | $56.70 | $1,701 |
| 95970 Electrical Nerve Conductivity | Facility | 28 | 18 | $11.90 | $333 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 28 | 17 | $19.60 | $549 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 18 | 15 | $11.47 | $206 |
| 99215 Office E&M - Established | Office | 17 | 16 | $87.26 | $1,483 |
| 99443 Telephone Services | Office | 14 | 11 | $60.84 | $852 |
By year: 2022 $5,465 for 74 services; 2023 $4,936 for 102 services; 2024 $16K for 407 services.
Medicare prescription drug claims, 2024
In 2024, the drug Allyson R Cunningham prescribed most often to Medicare patients was Levetiracetam, with 268 prescriptions and refills. In total Allyson R Cunningham wrote 1,994 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 268 | 569 | 66 | $16K |
| Lacosamide Generic | 238 | 417 | 52 | $30K |
| Lamotrigine Generic | 177 | 329 | 41 | $6,593 |
| Clobazam Generic | 138 | 252 | 32 | $16K |
| Briviact Brivaracetam | 80 | 114 | 13 | $163K |
| Divalproex Sodium Generic | 78 | 125 | 13 | $4,549 |
| Oxcarbazepine Generic | 73 | 103 | Under 11 | $11K |
| Zonisamide Generic | 61 | 89 | 13 | $1,996 |
| Vimpat Lacosamide | 60 | 84 | Under 11 | $74K |
| Clonazepam Generic | 58 | 74 | 27 | $543 |
| Xcopri Cenobamate | 54 | 60 | Under 11 | $68K |
| Topiramate Generic | 50 | 124 | 16 | $2,701 |
| Lamotrigine Er Lamotrigine | 50 | 90 | Under 11 | $24K |
| Epidiolex Cannabidiol (Cbd) | 47 | 52 | Under 11 | $220K |
| Carbamazepine Er Carbamazepine | 44 | 84 | 12 | $6,896 |
Brand drugs: 459 claims; generic drugs: 1,523 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Allyson R Cunningham were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.